These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33893002)

  • 1. Hyperglycemia results in decreased immune cell infiltration and increased viral load in the lung in a mouse model of RSV infection.
    Khodakhah F; Tahamtan A; Marzban M; Shadab A; Tavakoli-Yaraki M; Hashemi SM; Mokhatri-Azad T; Nakstad B; Salimi V
    Cytokine; 2021 Jul; 143():155539. PubMed ID: 33893002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.
    Wronski S; Dannenmaier J; Schild S; Macke O; Müller L; Burmeister Y; Seilheimer B; Müller M
    PLoS One; 2018; 13(4):e0195822. PubMed ID: 29672626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts.
    Salimi V; Mirzaei H; Ramezani A; Tahamtan A; Jamali A; Shahabi S; Golara M; Minaei B; Gharagozlou MJ; Mahmoodi M; Bont L; Shokri F; Mokhtari-Azad T
    Med Microbiol Immunol; 2018 Apr; 207(2):105-115. PubMed ID: 29256094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice.
    Zhou J; Yang XQ; Fu Z; Zhao XD; Jiang LP; Wang LJ; Cui YX
    Med Microbiol Immunol; 2008 Dec; 197(4):345-51. PubMed ID: 18058127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.
    Sharma A; Wu W; Sung B; Huang J; Tsao T; Li X; Gomi R; Tsuji M; Worgall S
    J Virol; 2016 May; 90(10):5068-5074. PubMed ID: 26962219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection.
    Empey KM; Orend JG; Peebles RS; Egaña L; Norris KA; Oury TD; Kolls JK
    PLoS One; 2012; 7(7):e40499. PubMed ID: 22792355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.
    Cormier SA; Shrestha B; Saravia J; Lee GI; Shen L; DeVincenzo JP; Kim YI; You D
    J Virol; 2014 Aug; 88(16):9350-60. PubMed ID: 24920801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection.
    Moore ML; Chi MH; Goleniewska K; Durbin JE; Peebles RS
    Viral Immunol; 2008 Sep; 21(3):327-39. PubMed ID: 18788941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challenge.
    Dulek DE; Newcomb DC; Toki S; Goliniewska K; Cephus J; Reiss S; Bates JT; Crowe JE; Boyd KL; Moore ML; Zhou W; Peebles RS
    J Virol; 2014 Sep; 88(17):9655-72. PubMed ID: 24920804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection.
    Fulton RB; Meyerholz DK; Varga SM
    J Immunol; 2010 Aug; 185(4):2382-92. PubMed ID: 20639494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary eosinophilia requires interleukin-5, eotaxin-1, and CD4+ T cells in mice immunized with respiratory syncytial virus G glycoprotein.
    Johnson TR; Rothenberg ME; Graham BS
    J Leukoc Biol; 2008 Sep; 84(3):748-59. PubMed ID: 18519743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.
    Tahamtan A; Tavakoli-Yaraki M; Shadab A; Rezaei F; Marashi SM; Shokri F; Mokhatri-Azad T; Salimi V
    Viral Immunol; 2018 May; 31(4):292-298. PubMed ID: 29461930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
    Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease.
    You D; Siefker DT; Shrestha B; Saravia J; Cormier SA
    Respir Res; 2015 Aug; 16(1):91. PubMed ID: 26231396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection.
    Stokes KL; Currier MG; Sakamoto K; Lee S; Collins PL; Plemper RK; Moore ML
    J Virol; 2013 Sep; 87(18):10070-82. PubMed ID: 23843644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.
    Waris ME; Tsou C; Erdman DD; Zaki SR; Anderson LJ
    J Virol; 1996 May; 70(5):2852-60. PubMed ID: 8627759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.